C Fotopoulou

No ORCID on file · 3 papers in corpus
guideline 2021
ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours
Facts, views & vision in ObGyn ·doi:10.52054/fvvo.13.2.016

The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group and the European Society for Gynaecological Endosco…

case-report 2016
Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer
Gynecologic oncology reports ·doi:10.1016/j.gore.2016.11.001

•Case describes a response to sunitinib in clear cell ovarian cancer.•Discussion of unique molecular characteristics of clear cell ovarian cancers•Practical points regarding dosing and toxicity when using sunitinib discussed.

other 2015
Statement by the Kommission Ovar of the AGO: The New FIGO and WHO Classifications of Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-0035-1558079

More than 25 years after the last revision, in 2012 the FIGO Oncology Committee began revising the FIGO classification for staging ovarian, Fallopian tube and primary peritoneal cancers. The new classification has become effective with its …